LYG-202 structure
|
Common Name | LYG-202 | ||
---|---|---|---|---|
CAS Number | 1175077-25-4 | Molecular Weight | 438.51600 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H30N2O5 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS06 |
Signal Word | Danger |
Use of LYG-202LYG-202, a flavonoid, has potent anti-angiogenic and antitumor activity. LYG-202 inhibits VEGF-stimulated HUVEC migration and tube formation. LYG-202 induces cancer cell apoptosis[1][2]. |
Name | 5-hydroxy-8-methoxy-7-(4-(4-methylpiperazin-1-yl)butoxy)-2-phenyl-4H-chromen-4-one |
---|---|
Synonym | More Synonyms |
Description | LYG-202, a flavonoid, has potent anti-angiogenic and antitumor activity. LYG-202 inhibits VEGF-stimulated HUVEC migration and tube formation. LYG-202 induces cancer cell apoptosis[1][2]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C25H30N2O5 |
---|---|
Molecular Weight | 438.51600 |
Exact Mass | 438.21500 |
PSA | 75.38000 |
LogP | 3.45640 |
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301 |
Precautionary Statements | P301 + P310 |
RIDADR | UN 2811 6.1 / PGIII |
Spatio-temporal regulation of the human licensing factor Cdc6 in replication and mitosis.
Cell Cycle 14 , 1704-15, (2015) To maintain genome stability, the thousands of replication origins of mammalian genomes must only initiate replication once per cell cycle. This is achieved by a strict temporal separation of ongoing ... |
lyg-202 |